Anavex Life Sciences Corp (AVXL)

[falconer66a]

Sorry, no mice.

Except it [the new neurology journal article about blarcamesine] is about mice and we have seen this drug after drug in mice.

Read a little closer. Not a mouse was involved. The study was blarcamesine working therapeutically in transgenic rat models that displayed Alzheimer-like amyloid pathology.

Later, I'll post a summary of the significance of this peer-reviewed journal article. As always before, Anavex 3-71 has safely succeeded. The drug's unique and proprietary MOA (mechanism of action) is further validated.

(I didn't read the article so closely myself; posted, now corrected, that the study was with blarcamesine. Nope, 3-71. Rats and 3-71, not mice and blarcamesine.)